Scientists track cancer drug in blood to personalize treatment
NCT ID NCT06030089
Summary
This study aimed to understand how the drug venetoclax works in older patients with acute myeloid leukemia (AML) who are receiving standard combination therapy. Researchers measured drug levels in patients' blood during their first treatment cycle to see how it affected cancer cells. The goal was to gather information that could help doctors personalize treatment for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Nice
Nice, France
-
Hopital la Conception
Marseille, France
Conditions
Explore the condition pages connected to this study.